cas 1354940-29-6|| where to buy 3-{[1,1'-Biphenyl]-4-yl}-6-(piperazin-1-yl)pyridazine

Produktname:3-{[1,1'-Biphenyl]-4-yl}-6-(piperazin-1-yl)pyridazine

IUPAC Name:3-{[1,1'-biphenyl]-4-yl}-6-(piperazin-1-yl)pyridazine

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM336176-10g	3-4 Weeks	ǆȅȅȤ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1354940-29-6 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1354940-29-6; Molekulare Formel:C20H20N4; Schmelzpunkt:-; SMILES-Code:C1(C2=CC=C(C3=CC=CC=C3)C=C2)=NN=C(N4CCNCC4)C=C1; Dichte:

: Katalognummer:CM336176; Molekulargewicht:316.4; Siedepunkt:; Mdl-Nr.:MFCD07386390; Lagerung:

: Pyridazines; Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.